Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 3
This trial was looking at different treatments for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) that had a high risk of coming back.
Cancer Research UK supported this trial.
Recruitment start: 6 April 2009
Recruitment end: 31 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Alan Burnett Professor Nigel Russell
Bloodwise
Cancer Research UK
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Pfizer
This is Cancer Research UK trial number CRUK/08/025.
Last reviewed: 12 Oct 2017
CRUK internal database number: 12498
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
